Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

H. pylori infection is not linked to PCOS or infertility.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

SHBG may be a useful early indicator and treatment target for PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.